← Browse by Condition
Medical Condition

tumor immunity

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04150744 Phase 2
Recruiting

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Enrollment
120 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →